Anti-nausea drug Zofran being tested because of its potential heart rhythm side effects By Dr Ananya Mandal, MD The United States health regulators Meals and Medication Administration are looking at the basic safety of GlaxoSmithKline’s anti-nausea medication Zofran generically referred to as ondansetron, to ascertain whether there is a potential threat of abnormal heart rhythm. According to the FDA in a statement, the drug may increase the threat of developing abnormal changes in the electric activity of the center, leading to a fatal heart rhythm potentially http://cialis-suisse.net/sildalis .
The authors conclude: ‘Since most typhoid fever among individuals treated in the usa is acquired abroad, ongoing surveillance also may help monitor global patterns of antimicrobial resistance of S Typhi. Reducing the burden of typhoid fever in the usa shall require increased attention to prevention procedures by travelers, including improved vaccination insurance among travelers to typhoid-endemic areas,’ especially among travelers visiting friends or family in India or its neighbors. ‘Further reductions in typhoid fever among travelers will depend on increased option of safe drinking water as well as improved sanitation and meals hygiene in typhoid endemic areas, measures that could go quite a distance toward reducing the global burden of typhoid fever.’ Editorial: Addressing the Global Disease Burden of Typhoid Fever ‘The article by Lynch and colleagues underscores the importance of travel in the global spread of S Typhi and, in particular, NARST isolates,’ writes Zulfiqar A.